4

Back to all posts

Oklahoma State University Begins Clinical Study of RenoVō® Equine Allograft
Renovo Barrel Study Header

Equine Amnio Solutions, LLC (EAS), a distributor of advanced equine allografts derived from equine amniotic tissues, announced today partnership with the Oklahoma State University College of Veterinary Medicine to conduct clinical evaluation of RenoVō® on equine limb wounds.

RenoVō® is an acellular, liquid allograft derived from amniotic tissues and is intended for equine homologous use. Amniotic tissues contain extracellular matrix proteins, growth factors, cytokines, carbohydrates, hyaluronic acid, and other elements which are essential for foal growth and development. Just as the amniotic membrane and fluid provide biologic and physiologic properties and act as a physical barrier during pregnancy, RenoVō® provides physical and physiological properties to cover and protect tissues.

The study, entitled “Efficacy and safety of an equine liquid amniotic tissue allograft on equine distal limb wound healing” is being conducted in conjunction with the university’s Equine Surgery and Sports Medicine faculty.

Lead Investigator Mike J. Schoonover, DVM, MS, DACVS-LA, DACVSMR stated, “Oklahoma State is pleased to partner with EAS and its affiliates in a study of RenoVō®. This is the first of several studies intended to evaluate the safety and clinical performance of the product in common horse injuries.”

RenoVō® donor tissue is recovered following strict guidelines. Donors are healthy mares and tissues are collected without harm to the mare or foal. At the time of delivery, the foal is delivered and the placenta and fluid, which are typically discarded, are saved. RenoVō® is subjected to stringent USP testing prior to release. The product is supplied in volumes of 1.5 cc, 3.0 cc and 5.0 cc.

About Equine Amnio Solutions

Equine Amnio Solutions, LLC (EAS) is the market leader in the distribution of advanced equine allografts derived from equine amniotic tissues. Our mission is to develop and provide innovative products to maximize the health and performance of horses across all breeds and athletic disciplines. For additional information, please visit www.equineamniosolutions.com.

About Oklahoma State University College of Veterinary Medicine

OSU’s College of Veterinary Medicine is one of 30 veterinary colleges in the United States and the only veterinary college in Oklahoma. For more information, visit https://vetmed.okstate.edu.

RenoVō® is a Registered Trademark of Equine Amnio Solutions, LLC.

You may want to read these articles

RenoVō® CASE STUDY: Ocular Squamous Cell Carcinoma

RenoVō® CASE STUDY: Ocular Squamous Cell Carcinoma

Case presentation: September 8, 2020: A 10-Year-Old Gelding presented to Milestone Veterinary Care, Backus, MN, with a conjunctival squamous cell carcinoma at the lateral canthus causing visual impairment and destruction of the eye. The attending veterinarian, Fonda...

RenoVō® CASE STUDY: Hoof Injury

RenoVō® CASE STUDY: Hoof Injury

Case presentation: On June 6, 2018, a Long yearling Quarter Horse race horse kicked a weak beam of a stall and torn his left front hoof as he was pulling back. The horse was treated with antibiotics and casted for 2 weeks. The injury persisted and showed sign of...

RenoVō® CASE STUDY: Bilateral Corneal Ulcers

RenoVō® CASE STUDY: Bilateral Corneal Ulcers

August 11, 2020: A horse presented to The Equine Performance Center, Ocala, FL, with bilateral corneal ulcers. Following eye examination, sub-palpebral lavage was placed in both eyes and IV catheter was placed. The horse received aggressive medical therapy including...